Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 27 09 2019
accepted: 16 01 2020
entrez: 3 3 2020
pubmed: 3 3 2020
medline: 9 3 2021
Statut: epublish

Résumé

Individuals with impaired immune responses, such as ventilated and cystic fibrosis patients are often infected with

Identifiants

pubmed: 32117268
doi: 10.3389/fimmu.2020.00117
pmc: PMC7031978
doi:

Substances chimiques

Cytokines 0
Elafin 0
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

117

Informations de copyright

Copyright © 2020 Villeret, Solhonne, Straube, Lemaire, Cazes, Garcia-Verdugo and Sallenave.

Références

J Mol Genet Med. 2008 Nov 29;3(1):167-75
pubmed: 19565019
Mucosal Immunol. 2018 Jan;11(1):21-34
pubmed: 28812547
PLoS Pathog. 2015 Jun 12;11(6):e1004869
pubmed: 26070066
Cell Host Microbe. 2016 Oct 12;20(4):458-470
pubmed: 27736644
J Clin Invest. 2009 Jul;119(7):1910-20
pubmed: 19487810
Pediatr Pulmonol. 1998 Dec;26(6):371-9
pubmed: 9888211
mBio. 2011 Sep 20;2(5):
pubmed: 21933918
Am J Respir Cell Mol Biol. 1994 Dec;11(6):733-41
pubmed: 7946401
J Immunol. 2004 Apr 1;172(7):4535-44
pubmed: 15034071
J Virol. 2013 Jun;87(12):6911-24
pubmed: 23596287
PLoS Pathog. 2012;8(4):e1002641
pubmed: 22496659
Paediatr Respir Rev. 2003 Sep;4(3):172-7
pubmed: 12880751
Thorax. 1996 Nov;51(11):1115-22
pubmed: 8958895
Front Immunol. 2018 Dec 14;9:2943
pubmed: 30619303
Thorax. 2018 Jan;73(1):49-61
pubmed: 28790180
PLoS One. 2012;7(11):e50052
pubmed: 23185529
Arch Dis Child. 1995 Aug;73(2):117-20
pubmed: 7574853
Nat Immunol. 2018 Dec;19(12):1299-1308
pubmed: 30374129
Gene Ther. 1998 Mar;5(3):352-60
pubmed: 9614555
J Immunol. 2018 Feb 15;200(4):1425-1433
pubmed: 29311363
Chest. 2012 Dec;142(6):1425-1432
pubmed: 22911225
Virus Res. 2013 Dec 26;178(2):411-22
pubmed: 24055463
ACS Nano. 2018 Feb 27;12(2):1188-1202
pubmed: 29357226
Am J Respir Cell Mol Biol. 2012 Aug;47(2):149-57
pubmed: 22383584
Clin Infect Dis. 2017 Jun 15;64(12):1760-1767
pubmed: 28329304
J Immunol. 2013 Nov 15;191(10):5153-9
pubmed: 24089191
Front Immunol. 2018 Dec 20;9:3067
pubmed: 30619379
J Med Invest. 2010 Feb;57(1-2):26-34
pubmed: 20299740
J Exp Med. 2008 Feb 18;205(2):323-9
pubmed: 18227219
J Immunol. 2001 Aug 1;167(3):1778-86
pubmed: 11466403
Pediatrics. 1999 Mar;103(3):619-26
pubmed: 10049966
J Immunol. 2011 Feb 1;186(3):1666-1674
pubmed: 21178015
Am J Physiol Lung Cell Mol Physiol. 2015 Jul 15;309(2):L158-67
pubmed: 26001778
Eur Respir J. 1999 May;13(5):1029-36
pubmed: 10414400
Arch Virol. 1999;144(7):1361-70
pubmed: 10481742
Infect Immun. 2003 Jul;71(7):3766-74
pubmed: 12819058
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24
pubmed: 23024024
Virology. 2016 Dec;499:23-29
pubmed: 27632562
Chest. 2013 Jul;144(1):39-47
pubmed: 23392627
Am J Respir Crit Care Med. 2013 Jan 15;187(2):170-9
pubmed: 23220915
Immunol Rev. 2018 Sep;285(1):97-112
pubmed: 30129197
Sci Rep. 2017 Feb 09;7:42243
pubmed: 28181563
J Infect Dis. 2014 Mar;209(6):865-75
pubmed: 24072844
Biochim Biophys Acta. 2012 Jan;1824(1):186-94
pubmed: 21801859
Semin Respir Crit Care Med. 2001 Jun;22(3):317-26
pubmed: 16088683
Front Immunol. 2018 Oct 29;9:2377
pubmed: 30420852
Curr Opin Crit Care. 2017 Oct;23(5):385-390
pubmed: 28777158
Front Immunol. 2018 Jul 23;9:1675
pubmed: 30083156
J Intensive Care Med. 2016 Aug;31(7):427-41
pubmed: 25990273
J Infect Dis. 1992 Oct;166(4):783-91
pubmed: 1527412
Virulence. 2018;9(1):1008-1018
pubmed: 29938577

Auteurs

Berengère Villeret (B)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.

Brigitte Solhonne (B)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.

Marjolène Straube (M)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.

Flora Lemaire (F)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.

Aurélie Cazes (A)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Bichat, Service de Pneumologie A, Paris, France.

Ignacio Garcia-Verdugo (I)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.

Jean-Michel Sallenave (JM)

Inserm, UMR1152, Laboratoire d'Excellence Inflamex, Département Hospitalo-Universtaire FIRE (Fibrosis, Inflammation and Remodeling), Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH